13F-HR filed by TYBOURNE CAPITAL MANAGEMENT (HK) LTD
TYBOURNE CAPITAL MANAGEMENT (HK) LTD filed this 13F-HR for the quarter ended 2025-03-31, filed 2025-05-15, with 5 holding rows worth $23,555,343.
- Accession
- 0001553936-25-000007
- Filer
- CIK 1553936
- Filed
- 2025-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2025
A holdings report, 5 entries on the cover page, a total value of $23,555,343 stated on the cover page (in dollars after the unit check, H1), rows summing to $23,555,343 with VALUE read as dollars as filed, 13F file number 028-15146. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ACELYRIN INC | 00445A100 | COM | 2,906,629 | $7,179,374 | dollars as filed | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 3,700,000 | $5,143,000 | dollars as filed | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 576,343 | $4,893,153 | dollars as filed | |
| FORTE BIOSCIENCES INC | 34962G208 | COMMON STOCK | 619,981 | $4,811,053 | dollars as filed | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 961,486 | $1,528,763 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001553936-25-000007 | this filing | 2025-05-15 | acceptance time not in the bulk data set |